Third Quarter and First Nine Months 2014

Similar documents
Third Quarter 2016 October 20, qlirogroup.com

Continued sales growth

First Quarter 2017 April 19, qlirogroup.com

16% sales growth and positive cash flow of SEK 72 million in Q2

Financial Results for the Second Quarter and First Six Months July 2011

Interim report for 1 January 31 March 2016

Half year report for 1 January 30 June 2018

Interim report for 1 January 30 September 2017

Half year report for 1 January 30 June 2017

31% sales growth for the full year The results are burdened by non- recurring items in the fourth quarter

Cloetta and LEAF to merge Creating a Nordic market leader. December 16, 2011

Hemfosa announces terms for rights issue

RECORD-BREAKING FOURTH QUARTER SALES AND EBITA AS MARKET CONDITIONS RETURN TO NORMAL

Interim report for 1 January 31 March 2017

Year-end Report 2017

Interim report for 1 January 31 March 2018

IMPACT COATINGS INTENDS TO EXECUTE FULLY GUARANTEED RIGHT ISSUE AND DIRECTED SHARE ISSUE

New Nordic Healthbrands AB (publ) Three month report January - March 2017

Dustin resolves on previously announced rights issue of approximately SEK 700 million

Helsingborg, 24 October 2014

Qliro Group - Q3 Interim Report. Marcus Lindqvist, CEO October 19, 2018

D. CARNEGIE & CO CONDUCTS RIGHTS ISSUE OF SEK 1,013 million

Auriant Mining AB (publ) announces its plan to arrange a partially underwritten rights issue of approximately 178 MSEK and a profit forecast for 2017

MODERN TIMES GROUP MTG AB ANNOUNCEMENT OF 2000 EARNINGS

Supplement to the prospectus regarding the invitation to subscribe for shares in Probi AB (publ) 2016

Half-year report January-June 2018 Published on July 18, 2018

YEAR-END REPORT FEBRUARY 2017 BILJANA PEHRSSON CEO ANDERS KVIST DEPUTY CEO AND CFO

Troax Group AB (publ) Hillerstorp 13th of February, 2019

PRECISE BIOMETRICS ANNOUNCES RIGHTS ISSUE OF ABOUT SEK 55 MILLION

Annual report Qliro Group AB (publ) Nasdaq Stockholm: QLRO

Interim report 1 January 31 March 2018 Actic Group AB

Martin Lindqvist, President & CEO Marco Wirén, CFO February 11, 2011

Raketech publishes prospectus and announces price range in connection with the listing on Nasdaq First North Premier

Troax Group AB (publ) Hillerstorp 8th of November, 2018

Interim Report. January September Alimak Group AB ALIG, SE

NEW NORDIC HEALTHBRANDS AB (publ) FULL-YEAR REPORT 2017

New Nordic Healthbrands AB (publ) Full-Year Report 2015

Q Interim Report. Record Sales & Higher Margins. Third quarter Highlights 1. Nine Months Highlights 1

Anoto announces a fully underwritten rights issue of approximately SEK 160 million and appoints Joonhee Won as an interim CEO

Interim report January-September 2017 Published on October 26, 2017

Highlights. PRESS RELEASE For immediate release

Q1 Presentation April, 2011

Interim report January-March 2018 Published on April 24, 2018

Strong sales and profit trend

Year-end report 2009 Published on 11 February 2010

PRESS RELEASE. Saab s Results January-September Saab presents the results for January-September 2018.

BioInvent issues private placement to US-based healthcare investor Omega Funds in parallel to offering a fully guaranteed rights issue

MODERN TIMES GROUP MTG AB FINANCIAL RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED 30 SEPTEMBER 2007

Q2 Presentation July, 2011

Q Presentation 1

RECORD SALES, EBITA AND CASH FLOW ACCELERATED ORGANIC GROWTH TO 19 %

Year-end Report 2016 January - December YEAR-END REPORT 2016 OCTOBER DECEMBER 2016 JANUARY DECEMBER 2016 TROAX GROUP FIGURES

Interim report January - March First quarter. The group in brief

Mekonomen Group has entered into an agreement to acquire FTZ and Inter-Team to expand operations into Denmark and Poland.

Group net sales increased by 12 percent to MSEK (107.2). At comparable exchange rates sales increased by 8 percent.

Interim Report January March 2017

Q Interim Report

Q Report. A quarter of investments. First quarter Highlights

Interim Report for January-September 2015

MODERN TIMES GROUP MTG AB INTERIM REPORT FOR THE THIRD QUARTER OF 2000 SALES UP 23%, TO SEK 3.8 BILLION, INCLUDING THE ACQUISITION OF TV1000.

New Nordic Healthbrands AB (publ) Nine Months Report Q January-September

ÅRSREDOVISNING INFORMATION REGARDING

YEAR-END REPORT JANUARY-DECEMBER 2016

Interim Report. July September July- Sept. Sept

Interim Report (January December 2013)

Martin Lindqvist, President & CEO Marco Wirén, CFO April 29, 2011

Very strong quarter for Medical Solutions

2017/Q1 Road Show Thule Group. Magnus Welander, Lennart Mauritzson April-May 2017

Group in Summary MEUR % % Revenue % %

Interim report January-September 2018 Published on October 25, 2018

Operating profit increased by 44 percent to 27.2 MSEK (19.0). Result after tax increased by 52 percent to 27.7 MSEK (18.3).

Interim report Q3, July September 2017 Stockholm, 25 October 2017

Invitation to acquire shares in Bygghemma Group First AB (publ)

Systemair YEAR-END REPORT. 1 May April 2008 (SEK million) Strong finish to year

Year-end report (1 Jan-31 Dec 2007) Continued improved results for Doro - Core business profitable and strong growth in Care Electronic

Q3 report November Per Strömberg, CEO Sven Lindskog, CFO

Interim Report for First Quarter 2015

TeliaSonera Interim Report January September 2015

Interim report 1 January 31 March 2017 Actic Group AB

Operating earnings (EBIT) were SEK 118 million (95), which corresponds to an operating margin of 5.8% (5.3).

Interim Report as of September 30, NorCell Sweden Holding 2 AB (publ) Group

Election of Chairman of the Annual General Meeting (agenda item 2)

BJÖRN BORG AB YEAR END REPORT JANUARY DECEMBER Weak finish

Interim Report January-September 2009

Alfa Laval AB (publ) Interim report January 1 March 31, 2005

CombiGene publishes the prospectus for the rights issue

Eltel announces rights issue

Fredrik Börjesson. Stefan Hedelius

Interim Report. January September High sales growth continues with strengthened order book. July September January September 2015

MODERN TIMES GROUP MTG AB FINANCIAL RESULTS FOR THE PERIOD JANUARY - JUNE 2003

P R E S S R E L E A S E

Strong earnings and high margin

Q Cherry AB (publ) Q Presentation 16 August 2018

New Nordic Healthbrands AB (publ) Six month report January - June 2016

Q1: Strong Sales and solid Cash Flow

P R E S S R E L E A S E

Background. A. Implementation of the Program

Year-end report 2017 January - December YEAR-END REPORT 2017 OCTOBER DECEMBER 2017 JANUARY DECEMBER 2017

customer cancellations

Q1 Q Q3 Q EUR million Jan-Mar 2018 Jan-Mar 2017 Change, % EUR million Jan-Dec 2017

Transcription:

Third Quarter and First Nine Months 2014 The following presentation is not a prospectus. Its purpose is to serve as information regarding the announced rights issue in CDON Group AB (publ) ("CDON Group"). This presentation must not be made public, published or distributed, in whole or in part, directly or indirectly, in or into the United States, Canada, Japan, Hong Kong or Australia or in any other country where such publication or distribution would be in breach of applicable laws or regulations or would necessitate further documentation being drawn up or registered, or would necessitate any other action being taken, in addition to the requirements laid down by Swedish law. For further information, please see the final page of this presentation. 1

Change of Group name 2

Rights issue of SEK 650 million 1 to capture growth opportunities 1 Launch and roll-out of Qliro Payment Solution ~300 MSEK 2 Expansion of subsidiaries, especially Nelly ~100 MSEK 3 Strengthen balance sheet by early redemption of convertible bond ~250 MSEK Total: 650 MSEK New transparent financial reporting New long-term financial targets per company substituting former targets for the Group The Board of CDON Group/Qliro Group has decided on a rights issue of SEK 650 million 1 to existing shareholders Fully committed and underwritten by Kinnevik and expected to be completed before year end 2014 3 1) Before transaction cost, which will be deducted from the issue proceeds allocated to Qliro Payment Solution and growth in subsidiaries

Highlights Sales growth of 21% and a positive operating profit in Q3 All segments showed sales growth Strong growth of 30% within Nelly in Q3 Launch of Qliro pilot test on Tretti.se Launch of Gymsector.com EU-site 4

FINANCIALS 5

Income Statement Net sales, excluding divested operations were up 21%. Gross margin amounted to 13.5% (12.6%). Operating profit (EBIT), adjusted for divested operations and non-recurring items, improved, amounting to SEK 1.5 (-17.2) million for the quarter. The Group s financial net amounted to SEK -8.1 (-6.3) million for the quarter. Tax income of SEK 1.9 (3.2) million. Excluding divested entities 2014 2013 2014 2013 (SEK million) Q3 Q3 Jan-Sep Jan-Sep Net Sales 1,121.2 928.8 3,317.2 2,888.1 Gross profit 151.5 117.0 502.6 413.4 Gross margin (%) 13.5% 12.6% 15.2% 14.3% EBITDA 8.3-12.1 19.4-10.5 EBITDA margin (%) 0.7% -1.3% 0.6% -0.4% EBIT 1.5-17.2 0.6-25.3 EBIT margin (%) 0.1% -1.9% 0.0% -0.9% Including divested entities EBIT 1.6-17.9 36.6-74.6 Financial Net -8.1-6.3-18.1-28.0 Income before tax -6.6-24.3 18.5-102.6 Net income -4.7-21.1 12.3-83.1 Basic earnings per share (SEK) -0.05-0.21 0.11-1.03 Diluted earnings per share -0.05-0.21 0.11-1.03 6

Cash Flow Cash flow from operating activities improved to SEK 4.3 (-15.2) million. Cash flow from operations decreased to SEK -97.7 (14.6) million, primarily attributable to a higher outflow relating to stockpiling ahead of the fourth quarter. 2014 2013 2014 2013 (SEK million) Q3 Q3 Jan-Sep Jan-Sep Cash flow from operating activities 4.3-15.2 9.6-83.6 Changes in working capital -102.0 29.8-202.7-193.0 Cash flow from operations -97.7 14.6-193.1-276.6 Cash flow from/to investing activities -24.2-11.4 11.4-21.3 Cash flow from operations in the first nine months improved by SEK 84 million. Cash flow from/to financing activities Change in cash and cash equivalents for the period -6.5-166.2-6.5 336.0-128.4-163.0-188.2 38.2 Cash flow from investing activities in Q3 amounted to SEK -24.2 (-11.4) million. Cash and cash equivalents at the period's start 230.1 327.2 288.9 126.1 Translation difference 0.7-0.5 1.8-0.5 Cash flow from financing activities amounted to SEK -6.5 (-166.2) million. Cash and cash equivalents at the period's end 102.4 163.8 102.4 163.8 7

Financial Position Inventory levels increased by around 21% to SEK 689.3 (569.5) million Cash and cash equivalents decreased by SEK 128.4 million in Q3, from SEK 230.1 million to SEK 102.4 (163.8) million Total consolidated assets increased by around 7% to SEK 1,748.9 (1,627.4) million. At the end of the quarter, the Group had a net debt position of SEK 136.1 (65.6) million, made up of cash and cash equivalents of SEK 102.4 million and the convertible bond with a book value of SEK 238.5 million. 2014 2013 (SEK million) 30-Sep 30-Sep Total non-current assets 767.8 723.2 Inventories 689.3 569.5 Total receivables 189.4 170.9 Cash and cash equivalents 102.4 163.8 Total assets 1,748.9 1,627.4 Total equity 698.9 673.3 Interest bearing liabilities 238.5 244.4 Non-interest bearing liabilites 811.4 709.6 Total equity and liabilities 1,748.9 1,627.4 8

New financial reporting and segments In order to improve disclosure in the reporting, a number of new key ratios will be reported from the third quarter. Additionally, the segment reporting is changed due to the new strategy. CDON.com and Lekmer will from now on be reported as separate segments. CDON.com and Lekmer previously formed the Entertainment segment. Segment sales distribution 9% 14% 37% The names of the Fashion- and Sports & Health-segments are changed to Nelly and Gymgrossisten respectively. 18% 22% The former Home & Garden-segment is renamed to Tretti, and comprises only Tretti after the divestment of Rum21 AB s operations. CDON Nelly Gymgrossisten Tretti Lekmer CDON Nelly Gymgrossisten Tretti Lekmer 9

BUSINESS SEGMENTS 10

Nelly Sales increased by 30% in the third quarter. Product margin of 47%. Sales of private label products accounted for 30% of total sales. Profitable in Sweden and Nordics. Operating profit (EBIT) continued to improve. Launch of new site and logotype. Q3 14 Q3 13 Growth YTD 14 YTD 13 Growth Net sales (SEK million) 244.2 187.8 30% 758.3 632.1 20% EBITDA (SEK million) -4.0-6.6-9.2-18.6 EBITDA margin (%) -1.6% -3.5% -1.2% -2.9% EBIT (SEK million) -5.3-7.1-12.4-19.9 EBIT margin (%) -2.2% -3.8% -1.6% -3.2% Active customers (thousand) 1,101 957 15% 1,101 957 15% Visits (thousand) 29,327 21,848 34% 94,676 79,624 19% Orders (thousand) 588 407 44% 1,858 1,391 34% AOV (SEK) 598 648-8% 590 639-8% 11

Gymgrossisten Sales increased by 20% in the third quarter. Sales of private label products accounted for 42% of total sales. Stable gross margin. Operating profit (EBIT) in the Nordics slightly better than last year. Q3 14 Q3 13 Growth YTD 14 YTD 13 Growth Net sales (SEK million) 203.6 169.0 20% 630.9 502.1 26% EBITDA (SEK million) 17.0 15.9 54.1 49.0 EBITDA margin (%) 8.3% 9.4% 8.6% 9.8% EBIT (SEK million) 16.2 14.8 51.8 46.3 EBIT margin (%) 8.0% 8.8% 8.2% 9.2% Active customers (thousand) 505 418 21% 505 418 21% Visits (thousand) 4,450 3,855 15% 15,076 12,772 18% Orders (thousand) 268 209 28% 816 661 24% AOV (SEK) 766 799-4% 777 754 3% Note: Adjusted for non-recurring items 12

Tretti Sales increased by 29% in the third quarter. Home & Garden category continues to grow. Operating profit (EBIT) rose in the third quarter as a result of increased sales volumes and improved gross margins. Q3 14 Q3 13 Growth YTD 14 YTD 13 Growth Net sales (SEK million) 160.3 124.6 29% 475.1 389.3 22% EBITDA (SEK million) 1.5 0.8 4.3 1.6 EBITDA margin (%) 1.0% 0.6% 0.9% 0.4% EBIT (SEK million) 0.8-0.1 1.9-1.3 EBIT margin (%) 0.5% -0.1% 0.4% -0.3% Active customers (thousand) 237 219 8% 237 219 8% Visits (thousand) 2,819 2,365 19% 8,553 7,109 20% Orders (thousand) 73 61 20% 224 186 21% AOV (SEK) 2,269 2,192 3% 2,211 2,189 1% 13

CDON.com Sales increased by 8% in the third quarter. Reported an operating result (EBIT) close to break even. Continued decline in sales of media products. 230 merchants have signed up for CDON.com Marketplace. Q3 14 Q3 13 Growth YTD 14 YTD 13 Growth Net sales (SEK million) 418.7 386.8 8% 1,215.2 1,222.9-1% EBITDA (SEK million) 1.3-7.3-3.9 4.0 EBITDA margin (%) 0.3% -1.9% -0.3% 0.3% EBIT (SEK million) -0.8-9.3-9.7-1.8 EBIT margin (%) -0.2% -2.4% -0.8% -0.1% Active customers (thousand) 1,719 1,919-10% 1,719 1,919-10% Visits (thousand) 17,485 19,171-9% 54,629 60,125-9% Orders (thousand) 773 848-9% 2,333 2,699-14% AOV (SEK) 539 454 19% 516 441 17% Note: Adjusted for non-recurring items 14

Lekmer Sales increased by 58% in the third quarter. Preparations for Decembers sales including inventory build-up. Lekmer s operating profit (EBIT) improved during the quarter. Q3 14 Q3 13 Growth YTD 14 YTD 13 Growth Net sales (SEK million) 95.6 60.6 58% 240.7 147.8 63% EBITDA (SEK million) -1.0-3.4-8.4-7.1 EBITDA margin (%) -1.1% -5.7% -3.5% -4.8% EBIT (SEK million) -1.5-3.7-9.7-7.8 EBIT margin (%) -1.6% -6.1% -4.0% -5.3% Active customers (thousand) 357 260 37% 357 260 37% Visits (thousand) 5,564 3,996 39% 14,540 10,472 39% Orders (thousand) 153 105 46% 393 264 49% AOV (SEK) 640 575 11% 623 554 12% 15

Forward looking statement Deliver balanced sales growth and increased market shares, especially in Nelly and Gymgrossisten. Qliro Payment Solution will be reported in the new segment Qliro Financial Services as of Q4 2014. Due to the large volumes during the fourth quarter Qliro Financial Services is expected to report a negative operating result of SEK 10-15 million in Q4 2014. Warehouse consolidation within CDON.com started in Q4 and will gradually be carried out during 12 months. Investments expected to amount to SEK 10-15 million. CDON Group has agreed to redeem the convertible bond in December 2014 for approximately SEK 250 million, subject to completion of the rights issue. Fully guaranteed rights issue is expected to be completed during Q4 2014. Change of Group name to Qliro Group subject to EGM approval. 16

THANK YOU! Next report: 28 January 2015 For further information, please visit cdongroup.com or contact ir@cdongroup.com, +46 (0) 10 703 20 00 Follow us on Twitter at twitter.com/cdongroup

IMPORTANT INFORMATION This presentation does not contain or constitute an invitation or an offer to acquire, sell, subscribe for or otherwise trade in shares, subscription rights or other securities in CDON Group. This document has not been approved by any regulatory authority. This document is not a prospectus and investors should not subscribe for or purchase any securities referred to in this presentation except on the basis of information provided in the prospectus to be published by CDON Group. In certain jurisdictions, the publication or distribution of this presentation may be subject to restrictions according to law and persons in those jurisdictions where this presentation has been published or distributed should inform themselves about and abide by such restrictions. This presentation may not be made public, published or distributed, in whole or in part, directly or indirectly, in or into the United States, Canada, Japan, Hong Kong or Australia or any other country where such action is wholly or partially subject to legal restrictions or where such action would require additional prospectuses, other offer documentation, registrations or other actions in addition to what follows from Swedish law. Nor may the information in this presentation be forwarded, reproduced or disclosed in such a manner that contravenes such restrictions or would require such additional prospectuses, other offer documentation, registrations or other actions. Failure to comply with this instruction may result in a violation of the United States Securities Act of 1933, as amended (the "Securities Act") or laws applicable in other jurisdictions. No subscription rights or new shares will be registered under the Securities Act or any provincial act in Canada and may not be transferred or offered for sale in the United States or Canada or to persons domiciled in Canada or on account of such persons other than pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act or in such exempt cases that do not require registration in accordance with any provincial act in Canada, respectively.